I Love Lund (LOVE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Oct, 2025Executive summary
Focused on supporting existing portfolio companies, with no new investments during the quarter.
Portfolio rebalancing continued, with partial divestments in listed holdings and increased allocation to unlisted companies.
Active participation in follow-on rounds for key holdings such as Beammwave, Parlametric, and Bionamic.
Engaged shareholders through events, pitch sessions, and networking activities, strengthening the local investment ecosystem.
Financial highlights
Operating result for Q3 was -678 TSEK, nearly unchanged from -681 TSEK in the same quarter last year.
Net result after financial items improved to -76 TSEK from -1.5 MSEK year-over-year for the quarter.
For the nine-month period, operating result was -2.3 MSEK (vs. -2.2 MSEK), and net result after financial items was -4.1 MSEK (vs. -4.5 MSEK).
Equity per share at period end was 83.48 SEK (102.74 SEK), and net asset value per share was 110.96 SEK.
Result per share for the quarter was -0.18 SEK (vs. -3.93 SEK).
Outlook and guidance
No formal forecasts provided; management expresses optimism for improved returns as the economic cycle turns.
Latest events from I Love Lund
- Full-year net result improved to SEK -4.8m, with a diversified, innovation-focused portfolio.LOVE
Q4 202523 Jan 2026 - NAV and book value rose in Q2, driven by portfolio gains and new investment in Lead Biologics.LOVE
Q2 202525 Jul 2025 - Net loss driven by write-downs, but strong equity and new capital raised for future investments.LOVE
Q3 202413 Jun 2025 - Improved results and increased investments mark a cautiously optimistic first half of 2024.LOVE
Q2 202413 Jun 2025 - Negative Q1 result driven by accounting change; local investment focus and strong equity remain.LOVE
Q1 20256 Jun 2025 - Losses increased on write-downs, but solvency and liquidity remain robust.LOVE
Q4 20246 Jun 2025